Preclinical and clinical studies increasingly show that the immune response plays a major role in radiotherapy.
Here, we investigated the role of major histocompatibility complex class I (MHC-I) molecules recognized by cytotoxic CD8+ T cells in the response to targeted alpha therapy (TAT).
POUGET Jean-Pierre;
PARACH A;
DAVID T;
KARAM Jihad;
BRUCHERTSEIFER Frank;
MORGENSTERN Alfred;
JARLIER Marta;
BARDIES M;
DESHAYES Emmanuel;
GUDIN-DE-VALLERIN A;
BOISSIERE F;
CRAPEZ E;
CONSTANZO Julie;
2025-11-07
Elsevier
JRC143753
1619-7089 (online),
https://www.sciencedirect.com/science/article/pii/S3051291325000047,
https://publications.jrc.ec.europa.eu/repository/handle/JRC143753,
10.1016/S3051-2913(25)00004-7 (online),
| Name | Country | City | Type |
|---|
This document is only visible at the Commission level.
You are not authorized to publish or distribute it outside the European Commission.
This is a public document. You can share this publication.
Datasets
| ID | Title | Public URL |
|---|
Dataset collections
| ID | Acronym | Title | Public URL |
|---|
Scripts / source codes
| Description | Public URL |
|---|
Additional supporting files
| File name | Description | File type |
|---|